Skip to main content
. 2018 Nov 5;4(2):e000809. doi: 10.1136/rmdopen-2018-000809

Figure 1.

Figure 1

Unadjusted Kaplan-Meier curves of drug discontinuation by route of administration. TCZ, tocilizumab; TCZ-IV, intravenous tocilizumab; TCZ-SC, subcutaneous tocilizumab.